In PBMCs, LRRK2 G2019S PD patients display an increased GCase activity compared with healthy controls15, while the activity of GCase in PBMCs from non-manifesting LRRK2 G2019S carriers is similar to that of controls. The gene discussed is LRRK2; the disease is Parkinson disease.